Tiziana Life Sciences Ltd (TLSA) Stock Price, Quote & News

Company Profile

Tiziana Life Sciences Ltd, a biotechnology company, engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for use in the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It is also developing TZLS-501, a...

Industry: Biotechnology

Sector: Healthcare

Phone: 44 20 7495 2379

Website: www.tizianalifesciences.com

Address:

14/15 Conduit Street, London, United Kingdom

HopehelpsU Dec. 24 at 1:14 PM

$TLSA BUY order in @ 1.45..... Come to Papa... Sold 1.56s on the offering fake hand off... Could be a Fleaflicker pass into the end zone coming on data .... Imagine positive data announced ➕️ ODD approval in the 1st QTR?

0 · Reply

Tradephoenix Dec. 23 at 2:17 PM

$TLSA great news for 2026 for MSA where there is currently no treatment

0 · Reply

Housatonic1864 Dec. 22 at 8:02 PM

$TLSA power hour/push💥

0 · Reply

Gegau001 Dec. 22 at 7:20 PM

$TLSA It doesn't matter what the current price is; if the values are good, it goes "bang!"... no matter how you're invested... that's what counts... I'll stick with it until the end... I think.

1 · Reply

Housatonic1864 Dec. 22 at 7:02 PM

$TLSA busted dropped another 4k, let’s go baby

0 · Reply

Housatonic1864 Dec. 22 at 6:21 PM

$TLSA I’ve got almost 8k in this stock. I’m just chilling until the inevitable 🏴‍☠️

0 · Reply

Housatonic1864 Dec. 22 at 5:38 PM

$TLSA $1.88 is my new PT

0 · Reply

HopehelpsU Dec. 20 at 7:55 PM

$TLSA The actions of this company over the past week were unconscionable... BUT...this turd could rally next month along with other small caps after tax selling tumbles. I'm still out, but contemplating another small entry IF we see 1.40 again. Not quite sure though... There's a lot of good stocks that have gotten crushed as well. RCAT....FLY...my 2 faves next week and going into 2026. SMR earned a small position, gov news could send it hard. GL

2 · Reply

Punk76 Dec. 20 at 1:23 PM

$TLSA hey go cubs Hope you're still in and don't give up on $TLSA I've been holding for 5 long years now, I believe in the science and think 2026 will be phenomenal year The problem with all these small bios is their share price can be a rollercoaster at times, but I've learnt with this and others to ride it out, until payday Wishing you all the best

1 · Reply

Housatonic1864 Dec. 19 at 9:09 PM

$TLSA so close, I’m not going to put anymore money in this stock until it’s at $1.85🫡

1 · Reply

Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman

Dec 17, 2025, 10:00 AM EST - 8 days ago

Tiziana Life Sciences to Ring the Closing Bell at Nasdaq

Dec 17, 2025, 8:45 AM EST - 8 days ago

Tiziana Life Sciences Doses First Patient in Phase 2 Alzheimer's Clinical Trial

Dec 15, 2025, 3:07 PM EST - 9 days ago

Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer

Dec 15, 2025, 7:30 AM EST - 10 days ago

Tiziana Life Sciences Announces Withdrawal of Proposed Public Offering

Dec 12, 2025, 2:10 PM EST - 12 days ago

Tiziana Life Sciences to Dose First Patient in Phase 2 Alzheimer's Trial

Dec 2, 2025, 7:00 AM EST - 23 days ago

Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company

Nov 25, 2025, 8:30 AM EST - 4 weeks ago

Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program

Nov 13, 2025, 8:30 AM EST - 6 weeks ago

Tiziana Life Sciences to Present at Jefferies Global Healthcare Conference

Oct 31, 2025, 9:43 AM EDT - 7 weeks ago

Tiziana Life Sciences: Foralumab's Intranasal Push Is A Good Moonshot

Oct 29, 2025, 7:00 AM EDT - 2 months ago

Tiziana Life Sciences to Present at BIO-Europe in Vienna, Highlighting Innovative Immunomodulation Therapy

Sep 30, 2025, 8:30 AM EDT - 3 months ago

Tiziana Life Sciences Invited to Attend Life Sciences Innovation Forum 2025 in Riyadh, Saudi Arabia

Sep 24, 2025, 8:30 AM EDT - 3 months ago

Tiziana Life Sciences Announces Poster Presentation on Intranasal Foralumab Clinical Trial at the 41st ECTRIMS Congress

Sep 15, 2025, 8:00 AM EDT - 3 months ago

Department of Defense Awards Grant to Advance Tiziana Life Sciences Intranasal Anti-CD3 Therapy for Spinal Cord Injury

Sep 5, 2025, 8:30 AM EDT - 3 months ago

Tiziana Life Sciences Announces Purchase of Shares by Chairman

Aug 14, 2025, 8:30 AM EDT - 4 months ago

Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab for Multiple System Atrophy

Aug 11, 2025, 9:00 AM EDT - 4 months ago

FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy

Jul 21, 2025, 7:00 AM EDT - 5 months ago

Tiziana Life Sciences Announces Immunologic Analysis of Nasal Foralumab in Moderate Alzheimer's Patient

Jun 13, 2025, 11:08 PM EDT - 6 months ago

Tiziana: Scope Of Foralumab Goes Beyond That Of Multiple Sclerosis Targeting

Jun 13, 2025, 10:30 AM EDT - 6 months ago

Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center

Jun 13, 2025, 8:30 AM EDT - 6 months ago

Tiziana Life Sciences to Present at the Bio International Convention

May 23, 2025, 7:00 AM EDT - 7 months ago

Tiziana Life Sciences Announces Interview Highlighting Intranasal Foralumab for the Treatment of Moderate Alzheimer's Disease

May 15, 2025, 8:00 AM EDT - 8 months ago

Journal of Clinical Nuclear Medicine Publishes Results of Tiziana's Nasal Foralumab in Study Treating Moderate Alzheimer's Disease

May 9, 2025, 7:00 AM EDT - 8 months ago

Tiziana Life Sciences Announces Significant Reduction in Microglia Activation in PET Scan of Moderate Alzheimer's Patient Treated with Intranasal Foralumab

May 6, 2025, 7:00 AM EDT - 8 months ago

Tiziana Life Sciences Announces Comprehensive Positive Results from Study of Nasal Foralumab in Patients with Multiple Sclerosis

Apr 23, 2025, 7:00 AM EDT - 8 months ago

Tiziana Life Sciences Announces University of Massachusetts Commences Dosing Intranasal Foralumab in Phase 2 Multiple Sclerosis Trial

Apr 2, 2025, 8:00 AM EDT - 9 months ago

Tiziana Life Sciences Announces Johns Hopkins University Commences Dosing Nasal Foralumab in Phase 2 Multiple Sclerosis Clinical Trial

Mar 25, 2025, 8:00 AM EDT - 9 months ago

Tiziana Life Sciences Announces Yale University Commences Intranasal Foralumab Dosing in Phase 2 Multiple Sclerosis Trial

Mar 17, 2025, 8:00 AM EDT - 10 months ago

Tiziana Life Sciences to Present at the 37th Annual Roth Conference

Mar 14, 2025, 8:30 AM EDT - 10 months ago

Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule

Mar 4, 2025, 8:00 AM EST - 10 months ago

Tiziana Life Sciences Files Investigational New Drug Application with FDA for ALS Phase 2 Clinical Trial

Feb 27, 2025, 8:00 AM EST - 10 months ago

Tiziana Life Sciences Announces Groundbreaking Study Published in Nature Neuroscience Demonstrating Positive Results for Nasal Anti-CD3 Therapy in Traumatic Brain Injury

Feb 25, 2025, 8:00 AM EST - 10 months ago

Tiziana Life Sciences Announces Long Covid Study to Complete in Second Quarter

Feb 21, 2025, 8:00 AM EST - 10 months ago

Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC

Feb 18, 2025, 8:00 AM EST - 11 months ago

Tiziana Life Sciences Announces Dosing of Additional Patients in Multiple Sclerosis Expanded Access Program

Feb 11, 2025, 9:15 AM EST - 11 months ago

Tiziana Life Sciences Announces TV Interview with First Patient Dosed with Moderate Alzheimer's Disease

Jan 23, 2025, 3:00 PM EST - 11 months ago

Tiziana Life Sciences Announces Positive Results in Treating Spinal Cord Injury With Nasal Anti-CD3

Jan 23, 2025, 8:54 AM EST - 1 year ago

Tiziana Life Sciences not to engage in capital raising activities for the immediate future

Jan 22, 2025, 4:05 PM EST - 1 year ago

Tiziana Life Sciences Announces Discovery of New Immune Biomarkers in Multiple Sclerosis Patients Treated with Nasal Foralumab

Jan 8, 2025, 7:00 AM EST - 1 year ago

Tiziana Life Sciences Announces Review Article Published in Nature Highlighting Foralumab's Potential in the Treatment of Neurological Disease

Nov 1, 2024, 1:00 PM EDT - 1 year ago

Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data

Oct 30, 2024, 10:29 PM EDT - 1 year ago

Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million

Aug 19, 2024, 7:00 AM EDT - 1 year ago

Tiziana Life Sciences Appoints New Chief Executive Officer

Jul 24, 2024, 7:00 AM EDT - 1 year ago

Tiziana Life Sciences Granted FDA Fast Track Designation

Jun 28, 2024, 11:01 AM EDT - 1 year ago

Tiziana Receives $3.4 Million in Non-Dilutive Funding

Jun 26, 2024, 7:00 AM EDT - 1 year ago

Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer's Disease with Foralumab

May 30, 2024, 7:00 AM EDT - 1 year ago

Tiziana Life Sciences Scientific Board Chairman to Receive Prestigious Award for Multiple Sclerosis Research

May 13, 2024, 7:00 AM EDT - 1 year ago

Tiziana Life Sciences Files for Orphan Drug Designation for Intranasal Foralumab

Apr 25, 2024, 10:00 AM EDT - 1 year ago

Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Receiving Intranasal Foralumab

Apr 23, 2024, 7:00 AM EDT - 1 year ago

Tiziana Life Sciences Announces FDA Allowance for Additional Twenty Patients to be Enrolled in the Intranasal Foralumab Multiple Sclerosis Expanded Access Program

HopehelpsU Dec. 24 at 1:14 PM

0 · Reply

Tradephoenix Dec. 23 at 2:17 PM

$TLSA great news for 2026 for MSA where there is currently no treatment

0 · Reply

Housatonic1864 Dec. 22 at 8:02 PM

$TLSA power hour/push💥

0 · Reply

Gegau001 Dec. 22 at 7:20 PM

$TLSA It doesn't matter what the current price is; if the values are good, it goes "bang!"... no matter how you're invested... that's what counts... I'll stick with it until the end... I think.

1 · Reply

Housatonic1864 Dec. 22 at 7:02 PM

$TLSA busted dropped another 4k, let’s go baby

0 · Reply

Housatonic1864 Dec. 22 at 6:21 PM

$TLSA I’ve got almost 8k in this stock. I’m just chilling until the inevitable 🏴‍☠️

0 · Reply

Housatonic1864 Dec. 22 at 5:38 PM

$TLSA $1.88 is my new PT

0 · Reply

HopehelpsU Dec. 20 at 7:55 PM

2 · Reply

Punk76 Dec. 20 at 1:23 PM

1 · Reply

Housatonic1864 Dec. 19 at 9:09 PM

$TLSA so close, I’m not going to put anymore money in this stock until it’s at $1.85🫡

1 · Reply

JohnTrack Dec. 19 at 6:21 PM

$TLSA update just came through https://www.rapidticker.com/news/tlsa-sec-filing-ee044d

0 · Reply

quodo Dec. 19 at 5:15 PM

Wake up! Bank of America says small caps are where the value is. That’s not a promise .. it’s a setup. The winners will be the ones actually executing. $CAPS isn’t hype. It’s math + discipline. Eventually the tape notices. $TLSA $NVDA $META $AAPL https://timesofindia.indiatimes.com/business/india-business/wall-street-outlook-for-2026-is-big-tech-dominance-fading-in-us-markets-what-analysts-have-to-say/articleshow/125951706.cms?utm_source=chatgpt.com

1 · Reply

Punk76 Dec. 19 at 4:06 PM

$TLSA $TLSA Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman

0 · Reply

s_danko Dec. 19 at 3:08 PM

$UBER same story as google earlier this year but with AV instead of search. there is absolutely no sign of slowdowns in ubers business $TLSA bulls will get wiped out and uber bulls will be rewarded

0 · Reply

Smedley1 Dec. 19 at 3:03 PM

$TLSA this stock only knows one direction…ugh

2 · Reply

SuperGreenToday Dec. 18 at 7:42 PM

$TLSA Share Price: $1.46 Contract Selected: Jun 18, 2026 $2.5 Calls Buy Zone: $0.26 – $0.32 Target Zone: $0.48 – $0.59 Potential Upside: 78% ROI Time to Expiration: 181 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Housatonic1864 Dec. 18 at 7:11 PM

$TLSA let me get this straight, all the good news and the SP sinks! WTF?

0 · Reply

Urge255 Dec. 18 at 4:50 PM

$SPY $TLSA I should have sold all my shit

0 · Reply

GoodAtStocks Dec. 18 at 4:49 PM

Probably shoulda sold all your $SPY and $TLSA when you had the chance... WHOOPS

0 · Reply

Huguenots Dec. 18 at 4:16 PM

$TLSA so is the chaos over?

0 · Reply

DataJim Dec. 18 at 12:19 AM

$TLSA I’ve heard people talking about TD Ameritrade and Robin Hood, not allowing them to sell when it was opportune. That sounds really shady/alarming. Fidelity always allows me to sell if my shares that I’m selling or out on loan not able to use the funds right away, but I am able to get the sale price at the instant that I decide to sell. It seems that would be pretty important requirement for any brokerage, especially for those swing trading and selling volatile stocks

3 · Reply

HopehelpsU Dec. 17 at 9:17 PM

$TLSA Ding dong 🖕 TLSA

0 · Reply

Market Cap	170.60M
Revenue (ttm)	0.00
Net Income (ttm)	-11.86M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	211,600
Avg Vol	307,464
Day's Range	N/A - N/A
Shares Out	116.85M
Stochastic %K	45%
Beta	-0.05
Analysts	Strong Buy
Price Target	$3.00